These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10723229)

  • 1. [The level of triglycerides, total cholesterol and HDL cholesterol in various stages of human immunodeficiency virus (HIV) infection].
    Rogowska-Szadkowska D; Borzuchowska A
    Pol Arch Med Wewn; 1999 Feb; 101(2):145-50. PubMed ID: 10723229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid and acute-phase protein alterations in HIV-1 infected patients in the early stages of infection: correlation with CD4+ lymphocytes.
    Treitinger A; Spada C; da Silva LM; Hermes EM; Amaral JA; Abdalla DS
    Braz J Infect Dis; 2001 Aug; 5(4):192-9. PubMed ID: 11712964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
    Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
    Levy AR; McCandless L; Harrigan PR; Hogg RS; Bondy G; Iloeje UH; Mukherjee J; Montaner JS
    Lipids Health Dis; 2005 Feb; 4():4. PubMed ID: 15705191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.
    Echeverria P; Guardiola M; González M; Vallvé JC; Bonjoch A; Puig J; Clotet B; Ribalta J; Negredo E
    Antiviral Res; 2015 Feb; 114():48-52. PubMed ID: 25500319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.
    Asztalos BF; Schaefer EJ; Horvath KV; Cox CE; Skinner S; Gerrior J; Gorbach SL; Wanke C
    Atherosclerosis; 2006 Jan; 184(1):72-7. PubMed ID: 15935358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
    Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.
    Polgreen PM; Fultz SL; Justice AC; Wagner JH; Diekema DJ; Rabeneck L; Weissman S; Stapleton JT
    HIV Med; 2004 May; 5(3):144-50. PubMed ID: 15139979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid concentration with reference to the clinical and immunological status of HIV infected men.
    Christeff N; Lortholary O; Casassus P; Thobie N; Dalle MT; Veyssier P; Guillevin L; Nunez EA
    Ann Med Interne (Paris); 1995; 146(7):490-5. PubMed ID: 8787290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
    Viganò A; Aldrovandi GM; Giacomet V; Merlo M; Martelli L; Beretta S; Luraschi P; Rombolà G; Mora S
    Antivir Ther; 2005; 10(8):917-24. PubMed ID: 16430197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
    Muhammad S; Sani MU; Okeahialam BN
    Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I; Abrão EP; Mikawa AY; Landgraf VO; da Costa PI
    Clin Chem Lab Med; 2004 May; 42(5):525-32. PubMed ID: 15202789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy.
    Vergis EN; Paterson DL; Wagener MM; Swindells S; Singh N
    Int J STD AIDS; 2001 Jul; 12(7):463-8. PubMed ID: 11394983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipids in HIV-infected patients: a prospective study in 95 patients.
    Constans J; Pellegrin JL; Peuchant E; Dumon MF; Pellegrin I; Sergeant C; Simonoff M; Brossard G; Barbeau P; Fleury H
    Eur J Clin Invest; 1994 Jun; 24(6):416-20. PubMed ID: 7957495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
    Beatty G; Chu J; Kulkarni K; Lipshutz G; Khalili M; Abbasi F; Stansell J; Reaven GM
    HIV Clin Trials; 2004; 5(6):383-91. PubMed ID: 15682351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
    Koppel K; Bratt G; Eriksson M; Sandström E
    Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Swanson B; Keithley JK; Zeller JM; Sha BE
    Nutrition; 2004; 20(11-12):1022-5. PubMed ID: 15561494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HIV infection and HAART on serum lipids in men.
    Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
    JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control study.
    Nguemaïm NF; Mbuagbaw J; Nkoa T; Alemnji G; Této G; Fanhi TC; Asonganyi T; Samé-Ekobo A
    HIV Med; 2010 Jul; 11(6):353-9. PubMed ID: 20345886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of lipid profile in human immunodeficiency virus infection.
    Mullamitha SA; Pazare AR
    J Assoc Physicians India; 1999 Jun; 47(6):622-4. PubMed ID: 10999162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.